Viatris wins court decision invalidating AstraZeneca's Symbicort patentThe district court determined that the patent is invalid on two separate grounds – lack of written description and lack of enablement, the company said. Lannett, Ypsomed AG ink deal on pen injector deviceLannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH. Cardinal Health's Outcomes platform chosen by Transaction Data Systems TDS is adding the Outcomes digital ecosystem to its portfolio of pharmacy solutions. Sun Pharma, SPARC ink deal for commercialization of phenobarbital for injection The product, which is awaiting FDA approval, is targeted at treating seizures in neonatal patients. Upsher-Smith extends generic Haldol line Upsher-Smith is now offering haloperidol tablets in unit dose packaging in 1 mg, 5 mg and 10 mg strengths. Lilly to begin rollout of Tempo personalized diabetes management platform The technology aims to help adults living with Type 1 or Type 2 diabetes and clinicians make informed, data-backed decisions. Long Grove intros generic Hemabate Generic hemabate is indicated for the treatment of postpartum hemorrhage due to uterine atony. NCPA debuts first episode of “Show Me” reality series The five-part video series follows real pharmacists as they try to start or improve immunization programs. Alembic receives FDA OK for generic Toradol Ketorolac tromethamine is indicated for the short-term management of moderately severe acute pain in adult patients. NCPA: Nearly all community pharmacies experiencing drug shortages Ninety-eight percent of community pharmacies are experiencing drug shortages, according to a recent survey conducted by NCPA. First Previous 170 171 172 173 174 Next Last
